TEVA-MORPHINE SR
TEVA CANADA LIMITED
Quick answers
Is there a shortage of TEVA-MORPHINE SR in Canada?
No. There is no current shortage of TEVA-MORPHINE SR 30MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
M-ESLON
ETHYPHARM INC
STATEX
KNIGHT THERAPEUTICS INC.
MS.IR
PURDUE PHARMA
MS CONTIN
PURDUE PHARMA
M.O.S. SULPHATE 50MG TAB
VALEANT CANADA LP / VALEANT CANADA S.E.C.
ORAMORPH SR TABLETS 100MG
Extended-ReleaseROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
DIN
02302772
Strength
30MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage History
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646